GENE ONLINE|News &
Opinion
Blog

Immunotherapy
A Combination Immunotherapy Shows Proof of Concept for ART-Free HIV Control in Early Human Study
2025-12-23
Adagene–Third Arc Bio Seal Up to $840M SAFEbody CD3 Deal to Advance Safer T-Cell Engagers
2025-11-20
Protein Suppression as Potential Pathway for Glioblastoma Immunotherapy
2025-03-18
Massive Data Analysis Advances Understanding of How Immunotherapy Works
2025-02-24
Cryptic Antigen Identified as New Immunotherapy Target for Ovarian Cancer
2025-02-24
New Ebola Virus Research Boosts Pandemic Preparedness
2025-02-24
Six Game-Changing Cancer Treatments Built for Unstoppable Growth in 2025 – Part I
2024-12-11
DualityBio, Partner of BioNTech and BeiGene, Files for Hong Kong IPO, Highlighting Several Potential First-in-Class ADCs
2024-08-29
Autoimmune Patients See Breakthrough Response to Allogeneic CD19-Targeted CAR-T Therapy
2024-07-18
Wistar and Accelerated Biosciences Partner to Develop Novel hTSCs Platform for Immunotherapies
2024-07-15
FDA Boxed Warning for CAR-T therapy, Affecting Bristol-Myers Squibb, Novartis, Janssen, Gilead Sciences
2024-01-24
Moderna To Collaborate With Harbour BioMed On Nucleic Acid-Based Cancer Therapies
2022-11-14
Zenas Picks Up $118 Million To Advance Phase 3 For Autoimmune Candidate
2022-11-10
Kura Oncology Boasts Immunotherapy Preliminary Trial Data Success
2022-10-26
Eucure Biopharma, Syncromune To Develop Intratumoral Immunotherapy
2022-10-20
1 2 3 8
LATEST
David vs. Goliath: Taiwan’s PGI Wins $23M Settlement in Sequencing Patent Dispute with U.S. PacBio
2026-03-13
Gut Microbiome Composition Predicts Long-term Cardiometabolic Health Outcomes in Diverse Urban Populations
2026-03-12
NVIDIA Ahead of GTC 2026: Markets Focus on Data Center Strength, PC Expansion, and the Next Technical Breakout
2026-03-12
Global and APAC Biopharma Watch: Capital Raising, Clinical Expansion, and Industry Moves in Focus
2026-03-12
Dividend Exchange Rate for Q3 2025 Announced by DEC on March 12, 2026
2026-03-12
NewHydrogen Files International Patent Application for ThermoLoop Technology to Enhance Hydrogen Production Efficiency
2026-03-12
BioGene Therapeutics Inc. Appoints Raj S. Pruthi as Director
2026-03-12
Scroll to Top